Monotherapy with ezetimibe (10 mg/d) reduces intestinal cholesterol absorption ... Ezetimibe does not interact with the drug-metabolizing cytochrome P450 system and can be combined with statins ...

Ezetimibe is a nonstatin low-density lipoprotein cholesterol-lowering small molecule drug. Ezetimibe is the only currently FDA-approved approved member of the of intestinal cholesterol reuptake ...

Banach suggests that giving these patients a statin and the cholesterol-lowering drug ezetimibe — rather than statins alone — can reduce the risk of early death by 19%, a major cardiovascular ...